Mechanisms navigating the TGF-β pathway in prostate cancer
Open Access
- 1 January 2015
- journal article
- Published by Elsevier in Asian Journal of Urology
- Vol. 2 (1) , 11-18
Abstract
No abstract availableKeywords
Funding Information
- NIH (RO1 DK 083761)
This publication has 77 references indexed in Scilit:
- T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 CytokineImmunity, 2011
- A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosisKidney International, 2011
- TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancerNature Communications, 2011
- Identification of an mRNP Complex Regulating Tumorigenesis at the Translational Elongation StepMolecular Cell, 2011
- Overexpression of Transforming Growth Factor β1 in Malignant Prostate Cells is Partly Caused by a Runaway of TGF-β1 Auto-induction Mediated Through a Defective Recruitment of Protein Phosphatase 2A by TGF-β Type I ReceptorUrology, 2010
- Roles for the type III TGF-β receptor in human cancerCellular Signalling, 2010
- 4E‐BP1 is a target of Smad4 essential for TGFβ‐mediated inhibition of cell proliferationThe EMBO Journal, 2009
- Generation of mice with conditionally activated transforming growth factor beta signaling through the TβRI/ALK5 receptorGenesis, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumorsJournal of Cell Biology, 2006